Johnson & Johnson
تفاصيل التقرير
Position on Clinical Trial Data Transparency
At Johnson & Johnson Innovative Medicine (J&J IM), we believe transparency of clinical trial data
advances science and medicine and is in the best interest of the patients who use our pharmaceutical
products and the providers who prescribe them. As such, we support the overall principles of greater
clinical trial data transparency, including registration and disclosure of clinical trial results in external
registries, publication of results in peer-reviewed journals, sharing of clinical...
advances science and medicine and is in the best interest of the patients who use our pharmaceutical
products and the providers who prescribe them. As such, we support the overall principles of greater
clinical trial data transparency, including registration and disclosure of clinical trial results in external
registries, publication of results in peer-reviewed journals, sharing of clinical...
نوع التقرير
تقرير استدامة شامل
اللغة
الإنجليزية
السنة
٢٠٢٤
الصيغة
PDF
معايير التقرير:
GRI
ISSB
UN SDG
تقارير مشابهة
(حسب الوسوم المحددة) القطاع / الجغرافيا
نوع التقرير
|
٢٠٢٣
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
نوع التقرير
|
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
نوع التقرير
|
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.